# Comparison of a Single Versus Double Perclose Technique for TAVR

Study · id `cardio:ct-nct06173115` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06173115](<https://clinicaltrials.gov/study/NCT06173115>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06173115

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 876 participants.

## Technical summary

Registry record NCT06173115. Randomized; no masking; primary purpose treatment. Start 2024-01-23 (actual); primary completion 2026-02-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 876 participants (enrolled count; ClinicalTrials.gov record NCT06173115, source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)
- Started: 2024-01-23 (actual) (ClinicalTrials.gov record NCT06173115, source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)
- Primary completion: 2026-02-13 (actual) (ClinicalTrials.gov record NCT06173115, source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)
- Completion: 2026-03-19 (actual) (ClinicalTrials.gov record NCT06173115, source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06173115, source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06173115-2026-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of a Single Versus Double Perclose Technique for TAVR
- Acronym: Single
- Condition: Severe Aortic Stenosis
- Intervention (Device): Perclose Proglide system
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: cd4b28a1a8faa31eedaa1fef1468e5c97df49040fe722b57554e9a8ae7c4c658
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
